119 related articles for article (PubMed ID: 9424132)
1. [Oral and esophageal aphthous ulcers in a child with AIDS successfully treated with colony stimulating factors (GM-CSF)].
Pocheville I; Gutiérrez C; González J
Enferm Infecc Microbiol Clin; 1997 Oct; 15(8):439-40. PubMed ID: 9424132
[No Abstract] [Full Text] [Related]
2. [Granulocyte and macrophage colony stimulating factor (GM-CSF) in patients with acquired immunodeficiency syndrome and neutropenia].
Martos A; Domínguez MA; Martínez Lacasa J; Podzamczer D
Med Clin (Barc); 1992 Jun; 99(5):196-7. PubMed ID: 1507903
[No Abstract] [Full Text] [Related]
3. Successful treatment of aphthous ulcerations in AIDS patients using topical granulocyte-macrophage colony-stimulating factor.
Herranz P; Arribas JR; Navarro A; Peña JM; González J; Rubio FA; Casado M
Br J Dermatol; 2000 Jan; 142(1):171-6. PubMed ID: 10651717
[TBL] [Abstract][Full Text] [Related]
4. Killing of Mycobacterium avium by neutrophils and monocytes from AIDS patients treated with recombinant granulocyte-macrophage colony-stimulating factor.
Cinti S; Coffey M; Sullivan A; Kazanjian P
J Infect Dis; 1999 Jul; 180(1):229-33. PubMed ID: 10353887
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
Jacobson JM; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Wu AW; Hooton TM; Sha BE; Shikuma CM; MacPhail LA; Simpson DM; Trapnell CB; Basgoz N
J Infect Dis; 1999 Jul; 180(1):61-7. PubMed ID: 10353862
[TBL] [Abstract][Full Text] [Related]
6. Images in HIV/AIDS. Painful oral ulcerations in a patient with AIDS.
Skiest DJ; Camelo-Piragua S; Meade L
AIDS Read; 2006 Oct; 16(10):531-2. PubMed ID: 17096471
[No Abstract] [Full Text] [Related]
7. Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on 5-FU-induced ulcerative mucositis in hamster buccal pouches.
Cho SA; Park JH; Seok SH; Juhn JH; Kim SJ; Ji HJ; Choo YS; Park JH
Exp Toxicol Pathol; 2006 Mar; 57(4):321-8. PubMed ID: 16414253
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS.
Brites C; Gilbert MJ; Pedral-Sampaio D; Bahia F; Pedroso C; Alcantara AP; Sasaki MD; Matos J; Renjifo B; Essex M; Whitmore JB; Agosti JM; Badaro R
J Infect Dis; 2000 Nov; 182(5):1531-5. PubMed ID: 11023477
[TBL] [Abstract][Full Text] [Related]
9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
11. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
[TBL] [Abstract][Full Text] [Related]
12. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
13. Odynophagia from aphthous ulcers of the pharynx and esophagus in the acquired immunodeficiency syndrome (AIDS).
Bach MC; Valenti AJ; Howell DA; Smith TJ
Ann Intern Med; 1988 Aug; 109(4):338-9. PubMed ID: 3395042
[No Abstract] [Full Text] [Related]
14. Safety of GM-CSF in patients with AIDS: a review of the literature.
Ross SD; DiGeorge A; Connelly JE; Whiting GW; McDonnell N
Pharmacotherapy; 1998; 18(6):1290-7. PubMed ID: 9855329
[TBL] [Abstract][Full Text] [Related]
15. Recurrent aphthous stomatitis, recurrent aphthous ulcers, recurrent oral ulcers, aphthae, canker sores.
Brazelton F
GMDA Bull; 1983 Oct; 50(10):219-20. PubMed ID: 6584386
[No Abstract] [Full Text] [Related]
16. Employment of recombinant human granulocyte-macrophage colony stimulating factor in oesophageal candidiasis in AIDS patients.
Capetti A; Bonfanti P; Magni C; Milazzo F
AIDS; 1995 Dec; 9(12):1378-9. PubMed ID: 8605060
[No Abstract] [Full Text] [Related]
17. [Hypereosinophilic syndrome induced by GM-CSF in a patient with AIDS. Possible response to alpha-interferon treatment].
Sastre JL; Escribano L; Montilla P; Ulibarrena C; Cancelas JA
Sangre (Barc); 1994 Oct; 39(5):398-9. PubMed ID: 7754449
[No Abstract] [Full Text] [Related]
18. Reduced toxoplasmastatic activity of monocytes from AIDS patients: a role for granulocyte-macrophage colony-stimulating factor.
Delemarre FG; Stevenhagen A; Kroon FP; van Furth R
Scand J Immunol; 1998 Feb; 47(2):163-6. PubMed ID: 9496693
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide effective for AIDS-related oral ulcers.
Thompson C
Lancet; 1995 Nov; 346(8985):1289. PubMed ID: 7475726
[No Abstract] [Full Text] [Related]
20. Bronchoesophageal fistula complicating aphthous esophageal ulcer in AIDS.
Fantry GT; Pichney LS
J Clin Gastroenterol; 1991 Oct; 13(5):603-5. PubMed ID: 1744413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
